Oil & Gas Review 2017

May 19, 2017

Companies covered: Natural Gas Services Group, Inc. (NYSE:NGS), Exxon Mobil Corporation (NYSE:XOM), Chevron Corporation (NYSE:CVX), Valero Energy Corporation (NYSE:VLO), PBF Energy Inc. (NYSE:PBF), HollyFrontier Corporation (NYSE:HFC), Anadarko Petroleum Corporation (NYSE:APC), Devon Energy Corporation (NYSE:DVN), SM Energy Company (NYSE:SM), PDC Energy, Inc. (NASDAQ:PDCE), Cenovus Energy Inc (NYSE:CVE), Trecora Resources (NYSE:TREC), Marathon Oil Corporation (NYSE:MRO), ConocoPhillips (NYSE:COP), Occidental Petroleum Corporation (NYSE:OXY), BP p.l.c. (NYSE:BP), YPF Sociedad Anonima (NYSE:YPF), Petroleo Brasileiro S.A.- Petrobras (NYSE:PBR), Hess Corporation (NYSE:HES), Murphy Oil Corporation (NYSE:MUR), Halliburton Company (NYSE:HAL), Baker Hughes Incorporated (NYSE:BHI), General Electric Company (NYSE:GE), Schlumberger N.V. (NYSE:SLB), FMC Technologies, Inc. (NYSE:FTI), AKER SOLUTIONS ASA NK1,08 (FRA:1AKA), National Oilwell Varco, Inc. (NYSE:NOV), SEVENTY SEVEN ENER COM USD0.01 (OTCMKTS:SVNT), Patterson-UTI Energy, Inc. (NASDAQ:PTEN), Key Energy Services, Inc. (NYSE:KEG), Basic Energy Services, Inc. (NYSE:BAS), Weatherford International plc (NYSE:WFT), Superior Energy Services, Inc. (NYSE:SPN), Mammoth Energy Services Inc (NASDAQ:TUSK), U.S. Silica Holdings, Inc. (NYSE:SLCA), Fairmount Santrol Holdings Inc (NYSE:FMSA), Hi-Crush Partners LP (NYSE:HCLP), Smart Sand Inc (NASDAQ:SND), Targa Resources, Inc. (NYSE:TRGP), Summit Midstream Partners, LP (NYSE:SMLP), Antero Resources Corporation (NYSE:AR), Tesla Motors, Inc. (NASDAQ:TSLA), Williams Companies, Inc. (The) (NYSE:WMB), TransCanada Corporation (NYSE:TRP), Sunoco Logistics Partners LP (NYSE:SXL), Plains All American Pipeline, L.P. (NYSE:PAA), ENERGY TRANSFER PARTNERS (NYSE:ETP), Antero Midstream Partners LP (NYSE:AM), RPC, Inc. (NYSE:RES), Transocean Ltd. (NYSE:RIG), Diamond Offshore Drilling, Inc. (NYSE:DO), ENSCO plc (NYSE:ESV), Noble Energy Inc. (NYSE:NBL), Precision Drilling Corporation (NYSE:PDS)

Buy ($175)

Banking Review 2017

May 19, 2017

Companies covered: Bank of America Corporation (NYSE:BAC), Citigroup Inc. (NYSE:C), Goldman Sachs Group, Inc. (The) (NYSE:GS), JPMorgan Chase & Co. (NYSE:JPM), Morgan Stanley (NYSE:MS), Bank Of New York Mellon Corporation (The) (NYSE:BK), Northern Trust Corporation (NASDAQ:NTRS), State Street Corporation (NYSE:STT), BB&T Corporation (NYSE:BBT), Fifth Third Bancorp (NASDAQ:FITB), First Horizon National Corporation (NYSE:FHN), Huntington Bancshares Incorporated (NASDAQ:HBAN), KeyCorp (NYSE:KEY), M&T Bank Corporation (NYSE:MTB), PNC Financial Services Group, Inc. (The) (NYSE:PNC), Regions Financial Corporation (NYSE:RF), SunTrust Banks, Inc. (NYSE:STI), U.S. Bancorp (NYSE:USB), Wells Fargo & Company (NYSE:WFC), Zions Bancorporation (NASDAQ:ZION), BlackRock, Inc. (NYSE:BLK), Principal Financial Group Inc (NYSE:PFG), Camden National Corporation (NASDAQ:CAC), S&T Bancorp, Inc. (NASDAQ:STBA), American Express Company (NYSE:AXP), FIRST REPUBLIC BANK (NYSE:FRC), Barclays PLC (NYSE:BCS), Deutsche Bank AG (NYSE:DB), Paragon Commercial Corporation (NASDAQ:PBNC), Eagle Bancorp, Inc. (NASDAQ:EGBN), MBT Financial Corp. (NASDAQ:MBTF), Evercore Partners Inc (NYSE:EVR), Apple Inc. (NASDAQ:AAPL), CIT Group Inc (NYSE:CIT), Leucadia National Corporation (NYSE:LUK), Apollo Global Management, LLC (NYSE:APO), The Blackstone Group L.P. (NYSE:BX), KKR & Co. L.P. (NYSE:KKR), The Carlyle Group L.P. (NASDAQ:CG), Waddell & Reed Financial, Inc. (NYSE:WDR), T. Rowe Price Group, Inc. (NASDAQ:TROW), Franklin Resources, Inc. (NYSE:BEN), Affiliated Managers Group, Inc. (NYSE:AMG), Invesco Ltd. (NYSE:IVZ), Legg Mason, Inc. (NYSE:LM), Allegiance Bancshares Inc. (NASDAQ:ABTX), Prosperity Bancshares, Inc. (NYSE:PB), IBERIABANK Corporation (NASDAQ:IBKC)

Buy ($175)

Insurance

May 05, 2017

Companies covered: American International Group, Inc. (NYSE:AIG), Chubb Corporation (The) (NYSE:CB), Allstate Corporation (The) (NYSE:ALL), Progressive Corporation (The) (NYSE:PGR), MetLife, Inc. (NYSE:MET), Prudential Financial, Inc. (NYSE:PRU), Aflac Incorporated (NYSE:AFL), Hartford Financial Services Group, Inc. (The) (NYSE:HIG), Reinsurance Group of America, Incorporated (NYSE:RGA), Lincoln National Corporation (NYSE:LNC), Voya Financial, Inc. (NYSE:VOYA), Principal Financial Group Inc (NYSE:PFG), The Travelers Companies, Inc. (NYSE:TRV), W.R. Berkley Corporation (NYSE:WRB), Everest Re Group, Ltd. (NYSE:RE), Axis Capital Holdings Limited (NYSE:AXS), Allied World Assurance Company Holdings, AG (NYSE:AWH), Prudential Financial, Inc. (NYSE:PRH), Unum Group (NYSE:UNM), CNO Financial Group, Inc. (NYSE:CNO), MGIC Investment Corporation (NYSE:MTG), Radian Group Inc. (NYSE:RDN), NMI Holdings Inc (NASDAQ:NMIH), AmTrust Financial Services, Inc. (NASDAQ:AFSI), Kinsale Capital Group Inc. (NASDAQ:KNSL), Third Point Reinsurance Ltd. (NYSE:TPRE), Crawford & Company (NYSE:CRD/B), Hallmark Financial Services, Inc. (NASDAQ:HALL)

Buy ($175)

Investing Strategies

May 05, 2017

Companies covered: Statoil ASA (NYSE:STO), CNOOC Limited (NYSE:CEO), Total SA (ADR) (NYSE:TOT), Royal Dutch Shell PLC (NYSE:RDS/A), BP p.l.c. (NYSE:BP), Skandinaviska Enskilda Banken AB (STO:SEB-A), Novartis AG (NYSE:NVS), Gilead Sciences, Inc. (NASDAQ:GILD), TJX Companies, Inc. (The) (NYSE:TJX), Amazon.com, Inc. (NASDAQ:AMZN), VF Corp (NYSE:VFC), Macy's Inc (NYSE:M), Danaher Corporation (NYSE:DHR), Fortive Corp (NYSE:FTV), Community Bank System, Inc. (NYSE:CBU), Goldman Sachs Group, Inc. (The) (NYSE:GS), Moelis & Company (NYSE:MC), JPMorgan Chase & Co. (NYSE:JPM), FIRST REPUBLIC BANK (NYSE:FRC), Twitter, Inc. (NYSE:TWTR), Alphabet Inc (NASDAQ:GOOG), Broadcom Ltd (NASDAQ:AVGO), Netflix, Inc. (NASDAQ:NFLX), Salesforce.com Inc (NYSE:CRM), Kinder Morgan, Inc. (NYSE:KMI), The Blackstone Group L.P. (NYSE:BX), Pernod Ricard SA (EPA:RI), Diageo plc (NYSE:DEO), Airbus Group SE (EPA:AIR), Boeing Company (The) (NYSE:BA), Christian Dior SA (EPA:CDI), LVMH Moet Hennessy Louis Vuitton SE (EPA:MC), Motorola Solutions, Inc. (NYSE:MSI), Axalta Coating Systems Ltd. (NYSE:AXTA), Sherwin-Williams Company (The) (NYSE:SHW), Valspar Corporation (The) (NYSE:VAL), Progressive Corporation (The) (NYSE:PGR), Expeditors International of Washington, Inc. (NASDAQ:EXPD), Hytera Communications Corp Ltd. (SHE:002583)

Buy ($175)

Medical Research, Diagnostic Substances & Life Science Tools

April 21, 2017

Companies covered: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG), Soligenix, Inc. (NASDAQ:SNGX), Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), ContraVir Pharmaceuticals (NASDAQ:CTRV), Cancer Genetics, Inc. (NASDAQ:CGIX), Advanced Accelerator Applications S.A. (NASDAQ:AAAP), BeiGene Ltd (ADR) (NASDAQ:BGNE), National Health Investors, Inc. (NYSE:NHI), GlycoMimetics, Inc. (NASDAQ:GLYC), Daxor Corporation (NYSEMKT:DXR), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Valeant Pharmaceuticals International, Inc. (NYSE:VRX), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), United Therapeutics Corporation (NASDAQ:UTHR), Catabasis Pharmaceuticals Inc (NASDAQ:CATB), Cellectis S.A. (NASDAQ:CLLS), Syndax Pharmaceuticals Inc (NASDAQ:SNDX), Pfizer, Inc. (NYSE:PFE), Amgen Inc. (NASDAQ:AMGN), Biogen Inc. (NASDAQ:BIIB), Celgene Corporation (NASDAQ:CELG), Gilead Sciences, Inc. (NASDAQ:GILD), Intel Corporation (NASDAQ:INTC), Xerox Corporation (NYSE:XRX), Microsoft Corporation (NASDAQ:MSFT), Apple Inc. (NASDAQ:AAPL), Astrazeneca PLC (NYSE:AZN), Galenica AG (VTX:VIFN), Loxo Oncology, Inc. (NASDAQ:LOXO), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Sanofi (NYSE:SNY), Portola Pharmaceuticals, Inc. (NASDAQ:PTLA), Puma Biotechnology Inc (NYSE:PBYI), Atara Biotherapeutics, Inc. (NASDAQ:ATRA), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Versartis, Inc. (NASDAQ:VSAR), Intra-Cellular Therapies Inc. (NASDAQ:ITCI), Sage Therapeutics, Inc. (NASDAQ:SAGE), Cempra, Inc. (NASDAQ:CEMP), Achaogen, Inc. (NASDAQ:AKAO), Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), Otonomy, Inc. (NASDAQ:OTIC), Spark Therapeutics, Inc. (NASDAQ:ONCE), Galapagos NV (NASDAQ:GLPG), bluebird bio, Inc. (NASDAQ:BLUE), Nektar Therapeutics (NASDAQ:NKTR), Clovis Oncology, Inc. (NASDAQ:CLVS), Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), Bristol-Myers Squibb Company (NYSE:BMY), TESARO, Inc. (NASDAQ:TSRO), uniQure N.V. (NASDAQ:QURE), Intrexon Corporation (NYSE:XON), ZIOPHARM Oncology Inc (NASDAQ:ZIOP), Fibrocell Science Inc (NASDAQ:FCSC), AquaBounty Technologies, Inc. (NASDAQ:AQB), Thermo Fisher Scientific Inc (NYSE:TMO), Waters Corporation (NYSE:WAT), Mettler-Toledo International, Inc. (NYSE:MTD), Novartis AG (NYSE:NVS), Merck & Company, Inc. (NYSE:MRK), Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), Illumina, Inc. (NASDAQ:ILMN), Physicians Realty Trust (NYSE:DOC), Global Medical REIT Inc (NYSE:GMRE), Healthcare Trust of America, Inc. (NYSE:HTA), ZELTIQ Aesthetics, Inc. (NASDAQ:ZLTQ), Allergan, Inc. (NYSE:AGN), Hologic, Inc. (NASDAQ:HOLX), Edwards Lifesciences Corporation (NYSE:EW), Medtronic, Inc. (NYSE:MDT), Boston Scientific Corporation (NYSE:BSX), Abbott Laboratories (NYSE:ABT), DexCom, Inc. (NASDAQ:DXCM), Insulet Corporation (NASDAQ:PODD), Tandem Diabetes Care, Inc. (NASDAQ:TNDM), Intuitive Surgical, Inc. (NASDAQ:ISRG), Cynosure, Inc. (NASDAQ:CYNO)

Buy ($175)

Pin It on Pinterest

Latest News